Cognitive Systems Launches Caregiver Aware, Enabling Service Providers to Enter the Remote Eldercare Industry
4.5.2022 14:50:00 EEST | Business Wire | Press release
Cognitive Systems Corp. announced today the launch of Caregiver Aware, a revolutionary advancement in preventative health. Working directly with service providers during development to understand their challenges, Caregiver Aware was designed with flexible go-to-market options that leverage providers’ existing infrastructure and hardware. Building on the success of its Home Aware security product that commercially launched in 2019, Caregiver Aware’s predictive analytics has the potential to significantly disrupt the broadband services market and our definition of “smart home.”
Caregiver Aware is powered by WiFi Motion™, which is currently active in over 70 countries and leverages connected IoT devices to transform the entire home into a motion-sensing network without additional hardware. It is an end-to-end solution featuring Cognitive Systems' patented algorithms, clean iOS and Android app interfaces. Backed by robust integration support from Cognitive’s QA and commercialization experts, the optimized data management system does not impact broadband performance. This launch represents a key moment for service providers looking to enter the rapidly growing field of remote eldercare by providing their customers with a tool for aging in place.
“Technology is accelerating the shift from reactive to proactive healthcare and we want to help lead that charge,” said Taj Manku, co-founder and CEO of Cognitive Systems. “Caregiver Aware has been on our product roadmap from the start, but the pandemic has made us all acutely aware of the need for innovation in preventative health. Our goal with this product is to create a bridge for service providers to build a care-focused ecosystem using data analytics, which will be a game-changing step in shaping future broadband services.”
Caregiver Aware is currently being trialed with service provider partners. It allows caregivers to complete remote wellness checks and view live motion in a loved one's home without intruding on their privacy or independence in the way cameras or wearable devices do. This launch represents the tip of the iceberg for remote eldercare monitoring, with new features already in development aimed at capturing behavioural patterns based on natural motion AI, improving localization and enabling customized notifications.
“As we worked towards a full-scale launch with more advanced features, user feedback confirmed immediate value in providing people with the peace of mind knowing a loved one is home, safe and active,” says Amanda Forsyth, Director of Product Management at Cognitive Systems. “This first iteration of Caregiver Aware is an important steppingstone towards a proactive health model and, with the majority of adults wanting to age in place, Caregiver Aware not only fills an industry need but a societal one.”
With aging populations around the world, the remote eldercare industry is poised to take off. However, with current world events and chip shortages, integration timelines can be lengthy. Service providers looking to enter the market need to start conversations now about where care solutions fit into their product roadmaps.
Learn more about how WiFi Sensing is ushering in a new era of preventative healthcare here.
About Cognitive Systems
Cognitive Systems Corp. is on a mission to transform the way WiFi networks are used. Its flagship technology, WiFi Motion™, uses wireless signals to sense motion in the home. WiFi Motion harnesses artificial intelligence and predictive analytics to reliably identify and localize motion for the smart home, home monitoring, and wellness monitoring markets. This patented technology is layered onto existing WiFi networks without additional hardware to enhance service provider and router manufacturer offerings.
www.cognitivesystems.com
https://www.linkedin.com/company/cognitive-systems-corp-/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220504005187/en/
Contact information
Press
Proof Strategies
Jillian Colucci
jcolucci@getproof.com
416-801-9851
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Doubtless Pet Care Launches to Provide Peace of Mind to Pet Parents and Help Their Pets Live Happier, Healthier Lives29.6.2026 11:15:00 EEST | Press release
Doubtless launches today with the goal of helping more pet parents across the world access quality care for the pets they love. The company brings together a leading global portfolio of pet insurance brands with a growing range of connected solutions designed to support pet parents at every stage of their pet’s life. With over 4,000 employees, Doubtless insures 6 million pets across 10 markets in North America, Europe and the United Kingdom. “Uncertainty about the financial commitments associated with having a pet should never keep families from experiencing the joy of a life with pets,” said Dirk Beeckman, CEO of Doubtless. “By harnessing the power of our international footprint, we are building on our leadership in pet insurance to create a global suite of solutions for pet parents, veterinarians and industry partners that makes pet care easier to access, navigate and manage. This will ultimately give pet parents better guidance, greater confidence and more control at every point in
Coolbrook Secures Business Finland Funding to Accelerate Electrification for the Global Steel Industry29.6.2026 11:00:00 EEST | Press release
Coolbrook, a transformational technology company dedicated to decarbonising heavy industry and industrial processes, has been awarded research and development funding by Business Finland to accelerate the decarbonisation of steel production. The grant supports Coolbrook’s participation in the FutSteel project, a core component of the Sustainable World through Steels ecosystem led by SSAB. Within the broader FutSteel project, Coolbrook’s project scope amounts to €5 million, of which €2.5 million is covered by grant funding awarded to Coolbrook. The funding will enable Coolbrook to further accelerate and develop its next-generation RotoDynamic Heater™ (RDH™) technology, specifically tailored for high-temperature steel industry applications. The project focuses on integrating RDH™ technology into critical stages of the steel production chain, including blast furnace processes, electrified reheating, hot-stove air pre-heating, hybrid-heating concepts, decarbonised Direct Reduced Iron (DRI)
Samsung Bioepis Announces Positive Preliminary Phase 1 and Phase 3 Data for SB27, a Proposed Biosimilar to Keytruda (Pembrolizumab)29.6.2026 10:19:00 EEST | Press release
Samsung Bioepis Co., Ltd. announced today that the Phase 1 and Phase 3 studies on SB27, a proposed biosimilar to Keytruda1 (pembrolizumab), have met their primary endpoints. “We are excited to announce preliminary results from the Phase 1 and Phase 3 studies for SB27, our pembrolizumab biosimilar candidate. These topline positive results reinforce our scientific expertise and leadership in biosimilar development,” said Donghoon Shin, Executive Vice President and Head of Clinical Sciences Division at Samsung Bioepis. “We are on track to complete both Phase 1 and Phase 3 studies within this year. Leveraging our robust quality management system, we remain committed to advancing our biosimilar portfolio to broaden access to life-saving biologic medicines for patients with unmet needs.” Pembrolizumab is a humanized monoclonal antibody that acts as an immune checkpoint inhibitor by targeting and blocking the programmed cell death protein 1 (PD-1) receptor on T cells. It is used to treat vari
IQM Named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment29.6.2026 10:00:00 EEST | Press release
IQM today announced it has been named a Major Player in the IDC MarketScape: Worldwide Quantum Computing 2026 Vendor Assessment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260629748732/en/ IQM named a major player in the IDC MarketScape IQM believes this recognition comes as institutions worldwide move quantum computing out of shared cloud access and into infrastructure they own and operate themselves. IQM calls this Production Quantum: full-stack, open-architecture superconducting systems deployed on premises, inside customers' own data centers and HPC environments, where organizations own the hardware, build internal expertise, and run quantum processors alongside their existing classical infrastructure. According to the IDC MarketScape, "For institutions building long-term quantum programs, this means the workflows and intellectual property developed on IQM hardware remain portable." The report further advises: "Consi
Zambon Announces Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson’s Disease and Moderate to Severe Motor Fluctuations29.6.2026 10:00:00 EEST | Press release
Zambon today announced that the Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a marketing authorization by the European Medicines Agency (EMA) for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/DDC inhibitor-based treatment regimens. CHMP recommendation is based on data from the Phase 3 RISE-PD trial, which compared Hopledo® with immediate release levodopa/carbidopa (LD/CD) formulation in patients with Parkinson’s disease and moderate to severe motor fluctuations. In the study, Hopledo® demonstrated a significant increase in Good ON time over immediate release LD/CD with fewer daily doses and a comparable safety profile1. Hopledo® is a first-in-class, oral, modified-release formulation of LD/CD designed for the treatment of fluctuations of Parkinson’s diseas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom